Abstract
Background: Growing antimicrobial resistance is of great concern in modern antibiotic era. Infections caused by multidrug resistant organisms like Klebsiella pneumoniae are among the leading causes of sepsis and infection related deaths.
Aim: This study was done to determine the prevalence of ESBL producing Klebsiella in the various clinical specimens by phenotypic methods.
Material and Methods: A prospective laboratory based study was done to determine phenotypically detect the presence of Extended Spectrum β-lactamases (ESBL’s) in samples received over a period of two years. A total of 7644 gram negative bacterial isolates were recovered from a total of 16526 clinical specimens received in the microbiology laboratory, over the two year period. Among the 2497 isolates of Klebsiella, 1157 isolates were ESBL positive (46%).
Conclusion: Drug resistant Klebsiella producing ESBL are hard to treat, and infections caused by them can lead to fatal outcome. Effective antibiotic policy and rational use must be strongly and promptly implemented in all healthcare setups.
Keywords: ESBL, Antibiogram, Drug resistant Klebsiella pneumoniae.
References
- Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med [Internet]. 2012 Jun [cited 2015 Aug 3];27(2):128–42. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3372794&tool=pmcentrez&rendertype=abstract
- Sikarwar A, Batra H. Challenge to healthcare: Multidrug resistance in Klebsiella pneumoniae. 2011 Int Conf Food Eng Biotechnol [Internet]. 2011;9:130–4. Available from: http://www.ipcbee.com/vol9/25-B060.pdf
- Poole K. Resistance to beta-lactam antibiotics. Cell Mol life Sci. 2004;61(17):2200–23.
- Jadhav S, Misra R, Gandham N, Ujagare M, Ghosh P, Angadi K, et al. Increasing incidence of multidrug resistance klebsiella pneumoniae infections in hospital and community settings. Int J Microbiol Res. 2012;4(6):253–7.
- Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589–603.
- Shanthi M, Sekar U. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. J Assoc Physicians India. 2010;58 Suppl:41–4.
- Bush K, Jacoby G a. Updated functional classification of Beta-lactamases. Antimicrob Agents Chemother. 2010;54 (3):969–76.
- Mackie and McCartney. Fungi. In Practical Medical Microbiology XIVth edn. Churchill Livingstone. 1996: 695-717.
- Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC Jr. Mycology. In colour Atlas and Textbook of Diagnostic Microbiology Vth edn. Lippincott, Philadelphia. 1997:983-1069.
- Hansen DS, Aucken HM, Abiola T, Podschun R. Recommended test panel for differentiation of Klebsiella species on the basis of a trilateral interlaboratory evaluation of 18 biochemical tests. J Clin Microbiol. 2004;42(8):3665–9.
- Alves MS, Dias RC da S, de Castro ACD, Riley LW, Moreira BM. Identification of clinical isolates of indole-positive and indole-negative Klebsiella spp. J Clin Microbiol [Internet]. 2006;44(10):3640–6.
- Jean B. Patel, Franklin R. JA. M100-S24:Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement.
- Al-Agamy MHM, Shibl AM, Tawfik AF. Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann Saudi Med. 2014;29(4):253–7.
- Chakraborty A, Adhikari P, Shenoy S, Baliga S, Rao S. Expression of ESBL , MBL and AmpC β lactamases by extra intestinal Escherichia coli isolates : correlation with treatment and clinical outcome. J Microbiol Infect Dis. 2013;3(4):150–6.
- Berrazeg M, Diene SM, Drissi M, Kempf M, Richet H, Landraud L, et al. Biotyping of Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates from France and Algeria Using MALDI-TOF MS. PLoS One. 2013;8(4).
- Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital. Indian J Med Res. 2002;115:153–7.
- Grover N, Sahni AK, Bhattacharya S. Therapeutic challenges of ESBLS and AmpC beta-lactamase producers in a tertiary care center. Med J Armed Forces India. 2013;69(1):4–10.
Corresponding Author
Dr Shefali Gupta
Senior Research Associate, Department of Virology, PGI Chandigarh
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
DOI: https://dx.doi.org/10.18535/jmscr/v6i7.129
